申请人:UNIVERSITY DE SANTIAGO DE COMPOSTELA
公开号:US20160297731A1
公开(公告)日:2016-10-13
The present invention relates to compounds of pharmaceutical interest. More particularly, it relates to compounds of formula (I), to processes for obtaining thereof, to the intermediates of their synthesis and processes for obtaining the latter. The compounds of formula (I) have a certain affinity with the vitamin D receptor, they are active in a similar order to 1,25α-dihydroxyvitamin D
3
(1,25D), with the advantage of producing less or no hypercalcemia.
本发明涉及具有药用兴趣的化合物。更具体地说,它涉及具有式(I)的化合物,其获得方法,其合成的中间体以及获得后者的方法。式(I)的化合物与维生素D受体具有一定的亲和力,它们的活性与1,25α-二羟基维生素D3(1,25D)相似,具有产生较少或无高钙血症的优点。